Additionally, in respiratory diseases such as COPD, the RNA-binding protein Alpha-2-Glycoprotein 1 (AZGP1) downregulates GBP5, modulating epithelial hyperplasia during disease progression (167). Here, GBP5 is linked to chronic obstructive pulmonary disease.